Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients

NCT06757153 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhongnan Hospital